United Therapeutics Corp. (UTHR)
473.42
-7.10
(-1.48%)
USD |
NASDAQ |
Feb 20, 16:00
472.79
-0.63
(-0.13%)
Pre-Market: 20:00
United Therapeutics Profit Margin (Quarterly) : 42.36% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 9.32% |
| Catalyst Pharmaceuticals, Inc. | 35.57% |
| MannKind Corp. | 9.72% |
| Madrigal Pharmaceuticals, Inc. | -18.24% |
| Vertex Pharmaceuticals, Inc. | 36.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.20% |
| Return on Assets | 16.93% |
| Return on Invested Capital | 18.69% |
| Gross Profit Margin (Quarterly) | 87.38% |
| Operating Margin (Quarterly) | 48.69% |
| Return on Net Operating Assets | 66.24% |